Omega-3 polyunsaturated Fatty acids and heart rate variability - PubMed (original) (raw)

Omega-3 polyunsaturated Fatty acids and heart rate variability

Jeppe Hagstrup Christensen. Front Physiol. 2011.

Abstract

Omega-3 polyunsaturated fatty acids (PUFA) may modulate autonomic control of the heart because omega-3 PUFA is abundant in the brain and other nervous tissue as well as in cardiac tissue. This might partly explain why omega-3 PUFA offer some protection against sudden cardiac death (SCD). The autonomic nervous system is involved in the pathogenesis of SCD. Heart rate variability (HRV) can be used as a non-invasive marker of cardiac autonomic control and a low HRV is a predictor for SCD and arrhythmic events. Studies on HRV and omega-3 PUFA have been performed in several populations such as patients with ischemic heart disease, patients with diabetes mellitus, patients with chronic renal failure, and in healthy subjects as well as in children. The studies have demonstrated a positive association between cellular content of omega-3 PUFA and HRV and supplementation with omega-3 PUFA seems to increase HRV which could be a possible explanation for decreased risk of arrhythmic events and SCD sometimes observed after omega-3 PUFA supplementation. However, the results are not consistent and further research is needed.

Keywords: autonomic function; heart rate variability; omega-3 polyunsaturated fatty acids; sudden cardiac death.

PubMed Disclaimer

Similar articles

• N-3 fatty acids and cardiac autonomic function in humans.
  Christensen JH, Svensson M, Strandhave C, Madsen T, Schmidt EB. Christensen JH, et al. Cell Mol Biol (Noisy-le-grand). 2010 Feb 25;56(1):131-9. Cell Mol Biol (Noisy-le-grand). 2010. PMID: 20196976
• n-3 fatty acids and the risk of sudden cardiac death. Emphasis on heart rate variability.
  Christensen JH. Christensen JH. Dan Med Bull. 2003 Nov;50(4):347-67. Dan Med Bull. 2003. PMID: 14694851 Review.
• Heart Rate Variability and Long Chain _n_-3 Polyunsaturated Fatty Acids in Chronic Kidney Disease Patients on Haemodialysis: A Cross-Sectional Pilot Study.
  Pinto AM, MacLaughlin HL, Hall WL. Pinto AM, et al. Nutrients. 2021 Jul 18;13(7):2453. doi: 10.3390/nu13072453. Nutrients. 2021. PMID: 34371962 Free PMC article.
• [Influence of Omega-3 PUFA on Non-invasive factors determining the risk of arrhYthmias eXcess and sudden cardiac death in patients with HFpEF with ischemic etiology (ONYX)].
  Mareev VY, Mareev YV. Mareev VY, et al. Kardiologiia. 2020 Nov 12;60(10):86-98. doi: 10.18087/cardio.2020.10.n1327. Kardiologiia. 2020. PMID: 33228511 Clinical Trial. Russian.
• Autonomic nervous system, heart rate variability and n-3 fatty acids.
  Christensen JH, Schmidt EB. Christensen JH, et al. J Cardiovasc Med (Hagerstown). 2007 Sep;8 Suppl 1:S19-22. doi: 10.2459/01.JCM.0000289276.10675.a1. J Cardiovasc Med (Hagerstown). 2007. PMID: 17876192 Review.

Cited by

• Adverse effects of gestational ω-3 and ω-6 polyunsaturated fatty acid imbalance on the programming of fetal brain development.
  Cinquina V, Keimpema E, Pollak DD, Harkany T. Cinquina V, et al. J Neuroendocrinol. 2023 Sep;35(9):e13320. doi: 10.1111/jne.13320. Epub 2023 Jul 27. J Neuroendocrinol. 2023. PMID: 37497857 Free PMC article. Review.
• A randomized clinical trial of omega-3 fatty acid and vitamin D supplementation on electrocardiographic risk profiles.
  Tikkanen JT, Soliman EZ, Pester J, Danik JS, Gomelskya N, Copeland T, Lee IM, Buring JE, Manson JE, Cook NR, Albert CM. Tikkanen JT, et al. Sci Rep. 2023 Jul 15;13(1):11454. doi: 10.1038/s41598-023-38344-x. Sci Rep. 2023. PMID: 37454148 Free PMC article. Clinical Trial.
• The beneficial effects of omega-3 polyunsaturated fatty acids on controlling blood pressure: An umbrella meta-analysis.
  Musazadeh V, Kavyani Z, Naghshbandi B, Dehghan P, Vajdi M. Musazadeh V, et al. Front Nutr. 2022 Aug 18;9:985451. doi: 10.3389/fnut.2022.985451. eCollection 2022. Front Nutr. 2022. PMID: 36061895 Free PMC article.
• Omega-3 fatty acid blood levels are inversely associated with cardiometabolic risk factors in HFpEF patients: the Aldo-DHF randomized controlled trial.
  Lechner K, Scherr J, Lorenz E, Lechner B, Haller B, Krannich A, Halle M, Wachter R, Duvinage A, Edelmann F. Lechner K, et al. Clin Res Cardiol. 2022 Mar;111(3):308-321. doi: 10.1007/s00392-021-01925-9. Epub 2021 Aug 28. Clin Res Cardiol. 2022. PMID: 34453204 Free PMC article.
• The Role of Biofactors in Diabetic Microvascular Complications.
  Ziegler D, Porta M, Papanas N, Mota M, Jermendy G, Beltramo E, Mazzeo A, Caccioppo A, Striglia E, Serhiyenko V, Serhiyenko A, Rosta L, Stirban OA, Putz Z, Istenes I, Horváth V, Kempler P. Ziegler D, et al. Curr Diabetes Rev. 2022;18(4):e250821195830. doi: 10.2174/1871527320666210825112240. Curr Diabetes Rev. 2022. PMID: 34433401 Free PMC article.

References

1. 1. Airaksinen K. E. (1999). Autonomic mechanisms and sudden death after abrupt coronary occlusion. Ann. Med. 31, 240–24510.3109/07853899908995886 - DOI - PubMed
2. 1. Akselrod S., Gordon D., Ubel F. A., Shannon D. C., Berger A. C., Cohen R. J. (1981). Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 213, 220–22210.1126/science.6166045 - DOI - PubMed
3. 1. Albert C. M., Campos H., Stampfer M. J., Ridker P. M., Manson J. E., Willett W. C., Ma J. (2002). Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N. Engl. J. Med. 346, 1113–111810.1056/NEJMoa012918 - DOI - PubMed
4. 1. Albert C. M., Hennekens C. H., O’Donnell C. J., Ajani U. A., Carey V. J., Willett W. C., Ruskin J. N., Manson J. E. (1998). Fish consumption and risk of sudden cardiac death. JAMA 279, 23–2810.1001/jama.279.1.23 - DOI - PubMed
5. 1. Barron H. V., Lesh M. D. (1996). Autonomic nervous system and sudden cardiac death. J. Am. Coll. Cardiol. 27, 1053–106010.1016/0735-1097(96)81523-3 - DOI - PubMed

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Frontiers Media SA
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database